Table of Content
1 Genitourinary Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Genitourinary Drugs
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Genitourinary Drugs industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Genitourinary Drugs Market Size, 2015 – 2020
2.1.2 Global Genitourinary Drugs Market Size by Type, 2015 – 2020
2.1.3 Global Genitourinary Drugs Market Size by Application, 2015 – 2020
2.1.4 Global Genitourinary Drugs Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Genitourinary Drugs Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Genitourinary Drugs Analysis
3.2 Major Players of Genitourinary Drugs
3.3 Genitourinary Drugs Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Genitourinary Drugs
3.3.3 Labor Cost of Genitourinary Drugs
3.4 Market Distributors of Genitourinary Drugs
3.5 Major Downstream Buyers of Genitourinary Drugs Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Genitourinary Drugs Market, by Type
4.1 Global Genitourinary Drugs Value and Market Share by Type (2015-2020)
4.2 Global Genitourinary Drugs Production and Market Share by Type (2015-2020)
4.3 Global Genitourinary Drugs Value and Growth Rate by Type (2015-2020)
4.3.1 Global Genitourinary Drugs Value and Growth Rate of Sex Hormones
4.3.2 Global Genitourinary Drugs Value and Growth Rate of Urologicals
4.3.3 Global Genitourinary Drugs Value and Growth Rate of Genitourinary Anti-Infectives
4.3.4 Global Genitourinary Drugs Value and Growth Rate of Gynaecologicals
4.4 Global Genitourinary Drugs Price Analysis by Type (2015-2020)
5 Genitourinary Drugs Market, by Application
5.1 Downstream Market Overview
5.2 Global Genitourinary Drugs Consumption and Market Share by Application (2015-2020)
5.3 Global Genitourinary Drugs Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Genitourinary Drugs Consumption and Growth Rate of Genitourinary Cancer (2015-2020)
5.3.2 Global Genitourinary Drugs Consumption and Growth Rate of Bladder Cancer (2015-2020)
5.3.3 Global Genitourinary Drugs Consumption and Growth Rate of Cervical Cancer (2015-2020)
5.3.4 Global Genitourinary Drugs Consumption and Growth Rate of Kidney/Renal Cancer (2015-2020)
5.3.5 Global Genitourinary Drugs Consumption and Growth Rate of Ovarian Cancer (2015-2020)
5.3.6 Global Genitourinary Drugs Consumption and Growth Rate of Prostate Cancer (2015-2020)
6 Global Genitourinary Drugs Market Analysis by Regions
6.1 Global Genitourinary Drugs Sales, Revenue and Market Share by Regions
6.1.1 Global Genitourinary Drugs Sales by Regions (2015-2020)
6.1.2 Global Genitourinary Drugs Revenue by Regions (2015-2020)
6.2 North America Genitourinary Drugs Sales and Growth Rate (2015-2020)
6.3 Europe Genitourinary Drugs Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Genitourinary Drugs Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Genitourinary Drugs Sales and Growth Rate (2015-2020)
6.6 South America Genitourinary Drugs Sales and Growth Rate (2015-2020)
7 North America Genitourinary Drugs Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Genitourinary Drugs Sales, Revenue and Market Share by Countries
7.2.1 North America Genitourinary Drugs Sales by Countries (2015-2020)
7.2.2 North America Genitourinary Drugs Revenue by Countries (2015-2020)
7.3 United States Genitourinary Drugs Sales and Growth Rate (2015-2020)
7.4 Canada Genitourinary Drugs Sales and Growth Rate (2015-2020)
7.5 Mexico Genitourinary Drugs Sales and Growth Rate (2015-2020)
8 Europe Genitourinary Drugs Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Genitourinary Drugs Sales, Revenue and Market Share by Countries
8.2.1 Europe Genitourinary Drugs Sales by Countries (2015-2020)
8.2.2 Europe Genitourinary Drugs Revenue by Countries (2015-2020)
8.3 Germany Genitourinary Drugs Sales and Growth Rate (2015-2020)
8.4 UK Genitourinary Drugs Sales and Growth Rate (2015-2020)
8.5 France Genitourinary Drugs Sales and Growth Rate (2015-2020)
8.6 Italy Genitourinary Drugs Sales and Growth Rate (2015-2020)
8.7 Spain Genitourinary Drugs Sales and Growth Rate (2015-2020)
8.8 Russia Genitourinary Drugs Sales and Growth Rate (2015-2020)
9 Asia Pacific Genitourinary Drugs Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Genitourinary Drugs Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Genitourinary Drugs Sales by Countries (2015-2020)
9.2.2 Asia Pacific Genitourinary Drugs Revenue by Countries (2015-2020)
9.3 China Genitourinary Drugs Sales and Growth Rate (2015-2020)
9.4 Japan Genitourinary Drugs Sales and Growth Rate (2015-2020)
9.5 South Korea Genitourinary Drugs Sales and Growth Rate (2015-2020)
9.6 India Genitourinary Drugs Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Genitourinary Drugs Sales and Growth Rate (2015-2020)
9.8 Australia Genitourinary Drugs Sales and Growth Rate (2015-2020)
10 Middle East and Africa Genitourinary Drugs Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Genitourinary Drugs Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Genitourinary Drugs Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Genitourinary Drugs Revenue by Countries (2015-2020)
10.3 Saudi Arabia Genitourinary Drugs Sales and Growth Rate (2015-2020)
10.4 UAE Genitourinary Drugs Sales and Growth Rate (2015-2020)
10.5 Egypt Genitourinary Drugs Sales and Growth Rate (2015-2020)
10.6 Nigeria Genitourinary Drugs Sales and Growth Rate (2015-2020)
10.7 South Africa Genitourinary Drugs Sales and Growth Rate (2015-2020)
11 South America Genitourinary Drugs Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Genitourinary Drugs Sales, Revenue and Market Share by Countries
11.2.1 South America Genitourinary Drugs Sales by Countries (2015-2020)
11.2.2 South America Genitourinary Drugs Revenue by Countries (2015-2020)
11.3 Brazil Genitourinary Drugs Sales and Growth Rate (2015-2020)
11.4 Argentina Genitourinary Drugs Sales and Growth Rate (2015-2020)
11.5 Columbia Genitourinary Drugs Sales and Growth Rate (2015-2020)
11.6 Chile Genitourinary Drugs Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Leucomax.
12.1.1 Leucomax. Basic Information
12.1.2 Genitourinary Drugs Product Introduction
12.1.3 Leucomax. Production, Value, Price, Gross Margin 2015-2020
12.2 Rhone Poulenc Rorer Inc.
12.2.1 Rhone Poulenc Rorer Inc. Basic Information
12.2.2 Genitourinary Drugs Product Introduction
12.2.3 Rhone Poulenc Rorer Inc. Production, Value, Price, Gross Margin 2015-2020
12.3 Anturol
12.3.1 Anturol Basic Information
12.3.2 Genitourinary Drugs Product Introduction
12.3.3 Anturol Production, Value, Price, Gross Margin 2015-2020
12.4 Immunex Corp.
12.4.1 Immunex Corp. Basic Information
12.4.2 Genitourinary Drugs Product Introduction
12.4.3 Immunex Corp. Production, Value, Price, Gross Margin 2015-2020
12.5 Agouron Pharmaceuticals Inc.
12.5.1 Agouron Pharmaceuticals Inc. Basic Information
12.5.2 Genitourinary Drugs Product Introduction
12.5.3 Agouron Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
12.6 Botox
12.6.1 Botox Basic Information
12.6.2 Genitourinary Drugs Product Introduction
12.6.3 Botox Production, Value, Price, Gross Margin 2015-2020
12.7 Pharmacia & John Inc
12.7.1 Pharmacia & John Inc Basic Information
12.7.2 Genitourinary Drugs Product Introduction
12.7.3 Pharmacia & John Inc Production, Value, Price, Gross Margin 2015-2020
12.8 Eli Lilly
12.8.1 Eli Lilly Basic Information
12.8.2 Genitourinary Drugs Product Introduction
12.8.3 Eli Lilly Production, Value, Price, Gross Margin 2015-2020
12.9 Hoffman-La Roche Inc.
12.9.1 Hoffman-La Roche Inc. Basic Information
12.9.2 Genitourinary Drugs Product Introduction
12.9.3 Hoffman-La Roche Inc. Production, Value, Price, Gross Margin 2015-2020
12.10 Betanis
12.10.1 Betanis Basic Information
12.10.2 Genitourinary Drugs Product Introduction
12.10.3 Betanis Production, Value, Price, Gross Margin 2015-2020
12.11 Bristol-Myers Squibb Co.
12.11.1 Bristol-Myers Squibb Co. Basic Information
12.11.2 Genitourinary Drugs Product Introduction
12.11.3 Bristol-Myers Squibb Co. Production, Value, Price, Gross Margin 2015-2020
12.12 Abbott Laboratories
12.12.1 Abbott Laboratories Basic Information
12.12.2 Genitourinary Drugs Product Introduction
12.12.3 Abbott Laboratories Production, Value, Price, Gross Margin 2015-2020
12.13 GlaxoSmithKline
12.13.1 GlaxoSmithKline Basic Information
12.13.2 Genitourinary Drugs Product Introduction
12.13.3 GlaxoSmithKline Production, Value, Price, Gross Margin 2015-2020
12.14 Glaxo Wellcome Plc
12.14.1 Glaxo Wellcome Plc Basic Information
12.14.2 Genitourinary Drugs Product Introduction
12.14.3 Glaxo Wellcome Plc Production, Value, Price, Gross Margin 2015-2020
12.15 Quadra Logic Technologies Inc.
12.15.1 Quadra Logic Technologies Inc. Basic Information
12.15.2 Genitourinary Drugs Product Introduction
12.15.3 Quadra Logic Technologies Inc. Production, Value, Price, Gross Margin 2015-2020
12.16 Pfizer
12.16.1 Pfizer Basic Information
12.16.2 Genitourinary Drugs Product Introduction
12.16.3 Pfizer Production, Value, Price, Gross Margin 2015-2020
12.17 Genentech Inc.
12.17.1 Genentech Inc. Basic Information
12.17.2 Genitourinary Drugs Product Introduction
12.17.3 Genentech Inc. Production, Value, Price, Gross Margin 2015-2020
12.18 Isis Pharmaceuticals
12.18.1 Isis Pharmaceuticals Basic Information
12.18.2 Genitourinary Drugs Product Introduction
12.18.3 Isis Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.19 Astellas
12.19.1 Astellas Basic Information
12.19.2 Genitourinary Drugs Product Introduction
12.19.3 Astellas Production, Value, Price, Gross Margin 2015-2020
12.20 Bayer AG
12.20.1 Bayer AG Basic Information
12.20.2 Genitourinary Drugs Product Introduction
12.20.3 Bayer AG Production, Value, Price, Gross Margin 2015-2020
12.21 Connaught Laboratories Inc.
12.21.1 Connaught Laboratories Inc. Basic Information
12.21.2 Genitourinary Drugs Product Introduction
12.21.3 Connaught Laboratories Inc. Production, Value, Price, Gross Margin 2015-2020
12.22 Merck & Co.
12.22.1 Merck & Co. Basic Information
12.22.2 Genitourinary Drugs Product Introduction
12.22.3 Merck & Co. Production, Value, Price, Gross Margin 2015-2020
12.23 Merck KGaA
12.23.1 Merck KGaA Basic Information
12.23.2 Genitourinary Drugs Product Introduction
12.23.3 Merck KGaA Production, Value, Price, Gross Margin 2015-2020
12.24 Chiron Inc.
12.24.1 Chiron Inc. Basic Information
12.24.2 Genitourinary Drugs Product Introduction
12.24.3 Chiron Inc. Production, Value, Price, Gross Margin 2015-2020
12.25 Schering Plough Corp
12.25.1 Schering Plough Corp Basic Information
12.25.2 Genitourinary Drugs Product Introduction
12.25.3 Schering Plough Corp Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Genitourinary Drugs Market Forecast
14.1 Global Genitourinary Drugs Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Sex Hormones Market Value and Volume Forecast (2020-2025)
14.1.2 Urologicals Market Value and Volume Forecast (2020-2025)
14.1.3 Genitourinary Anti-Infectives Market Value and Volume Forecast (2020-2025)
14.1.4 Gynaecologicals Market Value and Volume Forecast (2020-2025)
14.2 Global Genitourinary Drugs Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Genitourinary Cancer Market Value and Volume Forecast (2020-2025)
14.2.2 Bladder Cancer Market Value and Volume Forecast (2020-2025)
14.2.3 Cervical Cancer Market Value and Volume Forecast (2020-2025)
14.2.4 Kidney/Renal Cancer Market Value and Volume Forecast (2020-2025)
14.2.5 Ovarian Cancer Market Value and Volume Forecast (2020-2025)
14.2.6 Prostate Cancer Market Value and Volume Forecast (2020-2025)
14.3 Genitourinary Drugs Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
Get Free Sample